Cardioprotective Effect of Luseogliflozin in Patients with Type 2 Diabetes and Established Cardiovascular Disease | American Diabetes Association

Cardioprotective Effect of Luseogliflozin in Patients with Type 2 Diabetes and Established Cardiovascular Disease

Speaker: Yujiro Ina
Session: Links between Diabetes and Cardiovascular Disease
Congress: 79th Scientific Sessions